this is still early stage. The results are phase II. Company says they will seek partners after getting positive results from gastro studies in March, assuming the studies are as positive as early testing.
But painkiller market is gigantic, even for biotechs and this little company has a total market cap of C$47 after tripling off the bottom in December 2017. IF, big IF, everything goes their way, they should be a buyout candidate or have some hefty licensing deals on the way.
Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.
If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE